Merck defeats profits expectations, raises sales outlook on strong need for leading medicines like Keytruda - CNBC

.Merck defeats earnings assumptions, rears purchases outlook on sturdy requirement for top drugs like Keytruda CNBCMerck &amp Co. (MRK United States) Beats Profit Estimates as Keytruda Purchases Rise BloombergMerck Supply: Pharma Titan Posts Sturdy End Results, But Expectation Falls Short Financier's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings as well as purchases expectations amid Keytruda asset, yet gives combined full-year overview MarketWatch.